Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Wellcome Open Research|September 2, 2021
Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data ReportAnna Schultze, Chris Bates, Jonathan Cockburn, et al.Wellcome Open Research|February 11, 2025
Study protocol: Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform, Elizabeth J Williamson, John Tazare, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|November 9, 2021
Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients’ primary care records in situ using OpenSAFELYHelen J Curtis, Peter Inglesby, Caroline E Morton, et al.The Lancet Regional Health. Europe|January 17, 2022
Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65Anna Schultze, Emily Nightingale, David Evans, et al.The Lancet. Global Health|December 14, 2016
Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling studyDaouda Sissoko, Sophie Duraffour, Romy Kerber, et al.Diagnostic and Prognostic Research|February 24, 2022
Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform, Elizabeth J Williamson, John Tazare, et al.BMJ (Clinical Research Ed.)|July 20, 2022
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELYWilliam J Hulme, Elizabeth J Williamson, Amelia C A Green, et al.Wellcome Open Research|May 31, 2022
A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data ReportAnna Rowan, Chris Bates, William Hulme, et al.The Lancet. Rheumatology|June 14, 2022
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platformBrian MacKenna, Nicholas A Kennedy, Amir Mehrkar, et al.Proceedings. Biological Sciences|August 13, 2020
Key questions for modelling COVID-19 exit strategiesRobin N Thompson, T Déirdre Hollingsworth, Valerie Isham, et al.Pageof 15